For Novo Nordisk, Eli Lilly and Company, AstraZeneca, Amgen, Bayer, and Boehringer Ingelheim, GLP-1s, SGLT2s, and MRAs are being positioned at the center of CKM management
GLP-1 agonists like semaglutide and tirzepatide slow gastric emptying by 30-40% as part of their mechanism of action (Nauck et al., Diabetologia, 2011)
Glucagon-like peptide-1 receptor agonists and risk of acute pancreatitis in patients with type 2 diabetes
Topline GLP-1 diabetes and weight loss medications like Ozempic, Wegovy and Saxenda are being investigated by the European Union for causing suicidal thoughts, and while drug manufacturer Novo Nordisk denies a connection between suicide and its drugs, some studies and case reports suggest there could be a potential link
This is useful if you want to see if an underlying autoimmune condition, like Hashimotos, is contributing to your symptoms
The study was powered to assess non-inferiority and, if this was achieved, superiority of orforglipron 36 mg versus semaglutide 14 mg and of orforglipron 12 mg versus semaglutide 7 mg
